Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome

W Qu, Z Wang, JM Hare, G Bu… - Stem Cells …, 2020 - academic.oup.com
Severe cases of COVID-19 infection, often leading to death, have been associated with
variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal …

[PDF][PDF] Cell-based Therapy to Reduce Mortality From COVID-19: Systematic Review and Meta-Analysis of Human Studies on Acute Respiratory Distress Syndrome

H Murad, FP Sanfilippo - 2020 - gismonline.it
Severe cases of COVID-19 infection, often leading to death, have been associated with
variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal …

Cell‐based therapy to reduce mortality from COVID‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome

W Qu, Z Wang, JM Hare, G Bu… - STEM CELLS …, 2020 - Wiley Online Library
Severe cases of COVID‐19 infection, often leading to death, have been associated with
variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal …

[HTML][HTML] Cell‐based therapy to reduce mortality from COVID‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome

W Qu, Z Wang, JM Hare, G Bu, JM Mallea… - Stem Cells …, 2020 - ncbi.nlm.nih.gov
Severe cases of COVID‐19 infection, often leading to death, have been associated with
variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal …

[PDF][PDF] Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome

W Qu, Z Wang, JM Hare, G Bu, JM Mallea, JM Pascual… - 2020 - scienceopen.com
Severe cases of COVID-19 infection, often leading to death, have been associated with
variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal …

[引用][C] Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome

W Qu, Z Wang, JM Hare, G Bu, JM Mallea, JM Pascual… - 2020 - hero.epa.gov
Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of
human studies on acute respiratory distress syndrome | Health & Environmental Research …

[PDF][PDF] Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome

W Qu, Z Wang, JM Hare, G Bu, JM Mallea, JM Pascual… - 2020 - regenhealthsolutions.info
Severe cases of COVID-19 infection, often leading to death, have been associated with
variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal …

Cell‐based therapy to reduce mortality from COVID‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome

W Qu, Z Wang, JM Hare, G Bu… - Stem Cells …, 2020 - search.proquest.com
Severe cases of COVID‐19 infection, often leading to death, have been associated with
variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal …

Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.

W Qu, Z Wang, JM Hare, G Bu, JM Mallea… - Stem Cells …, 2020 - europepmc.org
Severe cases of COVID‐19 infection, often leading to death, have been associated with
variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal …